Evan Lipson

Associate Professor

20052019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Evan Lipson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Merkel Cell Carcinoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Programmed Cell Death 1 Receptor Medicine & Life Sciences
Antineoplastic Agents Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2005 2019

A Multidisciplinary Toxicity Team for Cancer Immunotherapy-Related Adverse Events

Naidoo, J., Zhang, J., Lipson, E., Forde, P., Suresh, K., Moseley, K., Mehta, S., Kwatra, S. G., Parian, A., Kim, A. K., Probasco, J. C., Rouf, R., Thorne, J. E., Shanbhag, S. P., Riemer, J., Shah, A., Pardoll, A. M., Bingham, C., Brahmer, J. & Cappelli, L., Jun 1 2019, In : Journal of the National Comprehensive Cancer Network : JNCCN. 17, 6, p. 712-720 9 p.

Research output: Contribution to journalArticle

Open Access
Immunotherapy
Referral and Consultation
Neoplasms
Odds Ratio
Educational Models

Cardiovascular toxicities associated with immune checkpoint inhibitors

Hu, J. R., Florido, R., Lipson, E., Naidoo, J., Ardehali, R., Tocchetti, C. G., Lyon, A. R., Padera, R. F., Johnson, D. B. & Moslehi, J., Apr 15 2019, In : Cardiovascular research. 115, 5, p. 854-868 15 p.

Research output: Contribution to journalArticle

Open Access
Programmed Cell Death 1 Receptor
Giant Cell Arteritis
Myositis
Myasthenia Gravis
Myocarditis
Teaching Rounds
Medical Oncology
Immunotherapy

Durable tumor regression and overall survival in patients with advanced Merkel cell carcinoma receiving pembrolizumab as first-line therapy

Nghiem, P., Bhatia, S., Lipson, E., Sharfman, W., Kudchadkar, R. R., Brohl, A. S., Friedlander, P. A., Daud, A., Kluger, H. M., Reddy, S. A., Boulmay, B. C., Riker, A. I., Burgess, M. A., Hanks, B. A., Olencki, T., Margolin, K., Lundgren, L. M., Soni, A., Ramchurren, N., Church, C. & 11 others, Park, S. Y., Shinohara, M. M., Salim, B., Taube, J. M., Bird, S. R., Ibrahim, N., Fling, S. P., Moreno, B. H., Sharon, E., Cheever, M. A. & Topalian, S., Mar 20 2019, In : Journal of Clinical Oncology. 37, 9, p. 693-702 10 p.

Research output: Contribution to journalArticle

Merkel Cell Carcinoma
Disease-Free Survival
Survival
Neoplasms
Merkel cell polyomavirus
Cell Biology
Melanoma
Lymph Nodes
Inflammation
Fine Needle Biopsy